Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01519583 · ClinicalTrials.gov registry record · NA
WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT01519583: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT01519583 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01519583, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The WalkMore study will help find out how walking interventions can help overweight/obese postmenopausal women with increased risk of cardiovascular disease lower their blood pressure.
Primary Outcome
Measured in the seated position using AHA blood pressure measurement guidelines
Interventions
- BEHAVIORAL Control Group
- BEHAVIORAL Basic Intervention
- BEHAVIORAL Enhanced Pedometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01519583 record still lists
NCT01519583 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Control Group is the first listed.
NCT01519583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01519583 about?
NCT01519583 is a clinical study titled "WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women". The WalkMore study will help find out how walking interventions can help overweight/obese postmenopausal women with increased risk of cardiovascular disease lower their blood pressure.
What is the current status of trial NCT01519583?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2012-05. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01519583?
The interventions under investigation include: Control Group (BEHAVIORAL), Basic Intervention (BEHAVIORAL), Enhanced Pedometry (BEHAVIORAL).
Who is sponsoring clinical trial NCT01519583?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01519583's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia